A61K - Preparations for medical, dental, or toilet purposes

More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)

Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
11/2011
11/09/2011	EP1633740B1 5-(acylamino)indazole derivatives as kinase inhibitors
11/09/2011	EP1592796B1 Helminth-derived antigens having capacity of providing protection against parasites
11/09/2011	CN101343251B Thrombopoietin mimetics
11/08/2011	US8053428 Vinorelbine derivatives
11/08/2011	US8053410 Pegylated factor VII glycoforms
11/08/2011	US8052966 gene therapy; producing targeted viral and non-viral particles delivery vectors for treating neoplastic disorders; retroviral, adenoviral, adeno-associated virus, Herpes Virus, and pseudotyped viruses, vesicular stomatitis virus G-protein (VSV-G), and to non-viral vectors that contain a viral protein
11/08/2011	CA2529126C Azetidine compounds
11/08/2011	CA2522738C Compounds for the treatment of metabolic disorders
11/08/2011	CA2507595C Use of dextran sulfate in the treatment of instant blood-mediated inflammatory reaction
11/03/2011	US20110269983 Production of very long chain polyunsaturated fatty acids in oilseed plants
11/03/2011	US20110269723 Spill resistant formulations containing clays
11/03/2011	US20110268754 Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy
11/02/2011	EP1667682B1 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
11/01/2011	US8048926 L-DOPA amide derivatives and uses thereof
11/01/2011	US8048913 Compositions and products containing S-equol, and methods for their making
11/01/2011	US8048850 Anticancer agents
11/01/2011	US8048407 In situ gelling self-reactive materials for embolization
11/01/2011	US8048222 Highly pure modafinil
11/01/2011	CA2522028C Methods and compositions for administration of trpv1 agonists
11/01/2011	CA2521621C Compounds for the treatment of metabolic disorders
11/01/2011	CA2521589C Compounds for the treatment of metabolic disorders
11/01/2011	CA2513092C Compounds for the treatment of metabolic disorders
11/01/2011	CA2473461C Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
11/01/2011	CA2458813C Anti-cancer cyclopenta[g]quinazoline compounds
11/01/2011	CA2375910C Tanacetum parthenium extract
10/2011
10/27/2011	US20110263706 Method for enhancing the dna repair process, treating disorders associated with the dna repair process, enhancing antitumor response and treating disorders associated with anti-tumor response in mammals by administering pruified quinic acid and/or carboxy alkyl ester
10/27/2011	US20110263625 Hiv replication inhibiting pyrimidines
10/27/2011	US20110262509 Anit-Virus Hydrophilic Polymeric Material
10/25/2011	CA2518299C 8-substituted-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one derivatives
10/20/2011	US20110256555 Use of cxcr4 protein expression on the surface of stem cells as a marker for tumor tropic potential
10/19/2011	EP1651161B1 Pharmaceutical compositions and methods for accelerating wound healing
10/19/2011	EP1084708B1 Method of processing medicated bath liquor of natural plant into medicinal powder
10/18/2011	US8039510 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3′-gallate and theaflavin 3,3′-digallate and mixtures thereof
10/18/2011	US8039471 Aza spiro alkane derivatives as inhibitors of metalloproteases
10/18/2011	US8039001 Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection
10/18/2011	CA2466499C Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis
10/13/2011	US20110251171 Heterocyclic compounds and methods of use
10/13/2011	US20110250631 Proteoglycan degrading mutants for treatment of cns
10/13/2011	US20110250174 Stable immunogenic product comprising antigenic heterocomplexes
10/12/2011	EP2374804A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
10/12/2011	CN102210852A Treatment of T-cell mediated diseases
10/12/2011	CN102210717A Compositions comprising Lactobacillus plantarum strains in combination with tannin and new Lactobacillus plantarum strains
10/11/2011	US8034977 Lipids for transfection of nucleic acids
10/11/2011	US8034821 Selective serine/threonine kinase inhibitors
10/11/2011	US8034604 High viscosity xanthan polymer preparations
10/11/2011	US8034346 Methods for treating pain by administering a nerve growth factor antagonist and an NSAID and compositions containing the same
10/11/2011	US8034334 Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy
10/11/2011	US8034314 Photoreactive compound specifically binding to calcium binding proteins
10/11/2011	CA2520523C Oral formulations of cladribine
10/11/2011	CA2508478C Withania somnifera composition, method for obtaining same and pharmaceutical, nutritional and personal care formulations thereof
10/06/2011	US20110245337 Method for enhancing the dna repair process, treating disorders associated with the dna repair process, enhancing antitumor response and treating disorders associated with anti-tumor response in mammals by administering purified quinic acid and/or carboxy alkyl ester
10/06/2011	US20110245189 Composition and method for the treatment of eye disease
10/06/2011	US20110245165 Peptide agonists of glp-1 activity
10/06/2011	US20110244032 Dispersible phospholipid stabilized microparticles
10/06/2011	US20110243930 Compositions and methods for the treatment of immune related diseases
10/05/2011	EP2371859A2 Treatment of TNF alpha related disorders
10/05/2011	EP2371839A1 Peptidomimetic protease inhibitors
10/05/2011	EP2371391A1 Therapeutic use of anti-CS1 antibodies
10/05/2011	EP2371361A1 Methods to mobilize progenitor/stem cells
10/05/2011	EP1708717B1 Atomoxetine for treatment of allergic rhinitis and asthma
10/05/2011	EP1653912B1 Vaccine immunotherapy for immune suppressed patients
10/05/2011	EP1267838B1 Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix
10/05/2011	CN1717251B Peptide-based passive immunization therapy for treatment of atherosclerosis
10/04/2011	US8030445 Glycopeptide derivative
10/04/2011	US8030362 Admixing a pharmaceutical agent with a foam forming agent; introducing the mixture of into a dispensing device; metered dose, external auditory meatus
10/04/2011	US8030330 Benzothiophenes, formulations containing same, and methods
10/04/2011	US8030279 Tamandarin analogs and fragments thereof and methods of making and using
10/04/2011	US8029769 Protein formulation
09/2011
09/29/2011	US20110237792 Quinoline derivatives and their use as 5-ht6 ligands
09/28/2011	EP2368901A1 Peptidomimetic protease inhibitors
09/28/2011	EP2368878A1 Peptidomimetic protease inhibitors
09/28/2011	EP2368877A1 Chiral intermediates for the preparation of peptidomimetic protease inhibitors
09/28/2011	EP1708751B1 Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells
09/28/2011	EP1617835B1 Compounds for the treatment of metabolic disorders
09/28/2011	CN1964714B Use of suberoylanilide hydroxamic acid and gemcitabine in preparing medicine for treating cancer
09/28/2011	CN1905899B EphA2 agonistic monoclonal antibodies and methods of use thereof
09/28/2011	CN101531631B Substituted pyridinones as modulators of p38 map kinase
09/27/2011	US8026286 Pharmaceutical compositions providing enhanced drug concentrations
09/27/2011	US8026263 Methods for inhibiting neoproliferative changes in blood vessel walls
09/27/2011	US8026223 Treating malignant tumors with high field strength electroporation of plasmids encoding IL-12
09/27/2011	US8026072 Method of identifying compounds that bind BAFF-R
09/27/2011	CA2532981C Ultra thin film transdermal/dermal or transmucosal/mucosal delivery system
09/27/2011	CA2530005C Use of buprenorphine for the treatment of drug dependence withdrawal in a pregnant woman
09/27/2011	CA2336218C Neurotrophic factors
09/22/2011	US20110230468 Fused heterocyclic compounds and uses thereof
09/22/2011	US20110229436 Methods for reducing the likelihood of spontaneous abortion during assisted reproduction in a subject
09/21/2011	EP1560588B1 Treatment for traumatic synovitis and damaged articular cartilage
09/21/2011	EP1003728B1 2-(3-(4-(2-t-Butyl-6-trifluoromethylpyrimidin-4-yl)piperazin-1-yl)propylmercapto)pyrimidin-4-ol-fumarate
09/21/2011	CN102188415A Method of treating cancer with HDAC inhibitors
09/21/2011	CN101343250B Thrombopoietin mimetics
09/20/2011	US8021833 Method for reducing HIV viral budding by administering a VPS28-specfic antibody that disrupts Gag-TSG101-VPS28 binding interactions
09/20/2011	CA2473686C Novel cytokine zcytor17 ligand
09/20/2011	CA2115828C Calcium receptor active molecules
09/15/2011	US20110224434 Prodrugs of Heteroaryl Compounds
09/15/2011	US20110224277 Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs
09/15/2011	US20110224153 Asthma Associated Factors as Targets for Treating Atopic Allergies Including Asthma and Related Disorders
09/15/2011	US20110223645 Multivalent Carriers of Bi-Specific Antibodies
09/15/2011	US20110223621 Combinations for the treatment of immunoinflammatory disorders
09/15/2011	US20110221083 Polymer-based microstructures
09/15/2011	US20110220539 Synthesis of high molecular weight iron-saccharidic complexes

1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 295